Patients News | pharmaphorum

News

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

UK body recommends COVID booster campaign in autumn

The UK's Joint Committee on Vaccination and Immunisation (JCVI) has recommended that the NHS should start a COVID-19 booster shot programme in September, to run alongside the annual flu vac

News

Mix and match regimen of AZ and Pfizer COVID jabs works well

Giving one dose each of AstraZeneca and Pfizer COVID-19 vaccines provides good protection against the SARS-CoV-2 virus, but may be associated with more adverse reactions, according to new c

News

J&J agrees to pay $263m to settle NY opioid claims, exits ma...

Johnson & Johnson has shaken off another lingering liability claim in the US, agreeing a $263 million settlement with New York to resolve lawsuits focused on its role in the US opioid c

News

FDA gives Roche's Actemra emergency okay for severe COVID

Roche has been granted emergency approval by the FDA for its arthritis drug Actemra as a treatment for patients aged two or over who are hospitalised with severe COVOD-19 symptoms.

News

UK trial will see if data trumps hype over ivermectin's role...

Despite limited data, anti-parasitic drug ivermectin has become widely used in some areas of the world as a treatment for COVID-19.

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AZ's COVID jab tackles delta variant, but antibody fails cli...

The delta variant of COVID-19 may be holding back the lifting of lockdown restrictions in the UK, but there is some good news – the AstraZeneca/Oxford University vaccine seems to offer a hi

UK body recommends COVID booster campaign in autumn

Mix and match regimen of AZ and Pfizer COVID jabs works well

J&J agrees to pay $263m to settle NY opioid claims, exits ma...

FDA gives Roche's Actemra emergency okay for severe COVID

UK trial will see if data trumps hype over ivermectin's role...

AZ's COVID jab tackles delta variant, but antibody fails cli...

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks